iShares Biotechnology ETF
782 hedge funds and large institutions have $7.35B invested in iShares Biotechnology ETF in 2020 Q3 according to their latest regulatory filings, with 97 funds opening new positions, 263 increasing their positions, 229 reducing their positions, and 75 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
6% less capital invested
Capital invested by funds: $7.8B → $7.35B (-$444M)
29% less funds holding in top 10
Funds holding in top 10: 24 → 17 (-7)
33% less call options, than puts
Call options by funds: $664M | Put options by funds: $986M
Holders
782
Holding in Top 10
17
Calls
$664M
Puts
$986M
Top Buyers
| 1 | +$247M | |
| 2 | +$143M | |
| 3 | +$67.8M | |
| 4 |
Squarepoint
New York
|
+$29.3M |
| 5 |
EP
Edgestream Partners
Princeton,
New Jersey
|
+$24.2M |
Top Sellers
| 1 | -$394M | |
| 2 | -$113M | |
| 3 | -$73.6M | |
| 4 |
JG
Jefferies Group
New York
|
-$70.5M |
| 5 |
CM
Churchill Management
Los Angeles,
California
|
-$56.4M |